Clinical trials recruiting for Neuroendocrine Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BL-M14D1 | 1 |
| DLL3-SAVVYZ-IL18 CAR T cell | 1 |
| Ivocizumab | 1 |
| ZG006 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New Jersey | 2 |
| New York | 2 |
| Alabama | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Georgia | 1 |
| Louisiana | 1 |
| Ohio | 1 |
| Oregon | 1 |
| South Carolina | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Armored CAR T Cells in People With Cancer
- Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
- Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Ivonescimab in the Treatment of Multiple Advanced Tumors
Related conditions
Trials recruiting for Neuroendocrine Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Neuroendocrine Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.